381 related articles for article (PubMed ID: 38273292)
1. Intratumoral microorganisms in tumors of the digestive system.
Xuan M; Gu X; Liu Y; Yang L; Li Y; Huang D; Li J; Xue C
Cell Commun Signal; 2024 Jan; 22(1):69. PubMed ID: 38273292
[TBL] [Abstract][Full Text] [Related]
2. ncRNAs associated with drug resistance and the therapy of digestive system neoplasms.
Feng W; Su Z; Yin Q; Zong W; Shen X; Ju S
J Cell Physiol; 2019 Nov; 234(11):19143-19157. PubMed ID: 30941775
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy as a perioperative biomarker of digestive tract cancers: review of the literature.
Shoda K; Saito R; Maruyama S; Furuya S; Akaike H; Kawaguchi Y; Amemiya H; Kawaida H; Sudo M; Inoue S; Kono H; Ichikawa D
Surg Today; 2021 Jun; 51(6):849-861. PubMed ID: 32979121
[TBL] [Abstract][Full Text] [Related]
4. Unravelling the role of intratumoral bacteria in digestive system cancers: current insights and future perspectives.
Lu W; Aihaiti A; Abudukeranmu P; Liu Y; Gao H
J Transl Med; 2024 Jun; 22(1):545. PubMed ID: 38849871
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA XIST predicts worse prognosis in digestive system tumors: a systemic review and meta-analysis.
Liu X; Ming X; Jing W; Luo P; Li N; Zhu M; Yu M; Liang C; Tu J
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29752340
[TBL] [Abstract][Full Text] [Related]
6. The RNA-Binding Protein HuR in Digestive System Tumors.
Song X; Shi X; Li W; Zhang F; Cai Z
Biomed Res Int; 2020; 2020():9656051. PubMed ID: 32775456
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA is a popular molecule in tumors of the digestive system (Review).
Wang HY; Wang YP; Zeng X; Zheng Y; Guo QH; Ji R; Zhou YN
Int J Oncol; 2020 Jul; 57(1):21-42. PubMed ID: 32377736
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin‑conjugating enzymes as potential biomarkers and therapeutic targets for digestive system cancers (Review).
Lei X; Hu X; Lu Q; Fu W; Sun W; Ma Q; Huang D; Xu Q
Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36799184
[TBL] [Abstract][Full Text] [Related]
9. Current understanding of the intratumoral microbiome in various tumors.
Xue C; Chu Q; Zheng Q; Yuan X; Su Y; Bao Z; Lu J; Li L
Cell Rep Med; 2023 Jan; 4(1):100884. PubMed ID: 36652905
[TBL] [Abstract][Full Text] [Related]
10. The Interaction between Intratumoral Microbiome and Immunity Is Related to the Prognosis of Ovarian Cancer.
Sheng D; Yue K; Li H; Zhao L; Zhao G; Jin C; Zhang L
Microbiol Spectr; 2023 Mar; 11(2):e0354922. PubMed ID: 36975828
[TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of 55 ovarian metastatic tumors from digestive system].
Xu L; Zhan YQ
Ai Zheng; 2002 Mar; 21(3):311-3. PubMed ID: 12452002
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of lncRNA NEAT1 as a New Biomarker in Digestive System Tumors: a Systematic Study and Meta-analysis.
Guo L; Tang Y; Wang Y; Xu H
Expert Rev Mol Diagn; 2021 Jan; 21(1):91-99. PubMed ID: 33550874
[TBL] [Abstract][Full Text] [Related]
13. What is New in the 2019 World Health Organization (WHO) Classification of Tumors of the Digestive System: Review of Selected Updates on Neuroendocrine Neoplasms, Appendiceal Tumors, and Molecular Testing.
Assarzadegan N; Montgomery E
Arch Pathol Lab Med; 2021 Jun; 145(6):664-677. PubMed ID: 32233993
[TBL] [Abstract][Full Text] [Related]
14. [Neuroendocrine carcinoma of the digestive tract: a literature review].
Jacob J; Chargari C; Helissey C; Ferrand FR; Ceccaldi B; Le Moulec S; Bauduceau O; Fayolle M; Védrine L
Rev Med Interne; 2013 Nov; 34(11):700-5. PubMed ID: 23871177
[TBL] [Abstract][Full Text] [Related]
15. Role of the intratumoral microbiome in tumor progression and therapeutics implications.
Meng YF; Fan ZY; Zhou B; Zhan HX
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189014. PubMed ID: 37918451
[TBL] [Abstract][Full Text] [Related]
16. Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis.
Wu J; Hu L; Wu F; Zou L; He T
Oncotarget; 2017 May; 8(19):32332-32344. PubMed ID: 28415659
[TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNA UCA1 Overexpression Is Associated with Poor Prognosis in Digestive System Malignancies: A Meta-analysis.
Shi FT; Chen LD; Zhang LF
Curr Med Sci; 2019 Oct; 39(5):694-701. PubMed ID: 31612385
[TBL] [Abstract][Full Text] [Related]
18. The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors.
Li XP; Qu J; Teng XQ; Zhuang HH; Dai YH; Yang Z; Qu Q
Int J Biol Sci; 2023; 19(4):1036-1048. PubMed ID: 36923930
[TBL] [Abstract][Full Text] [Related]
19. The effect of the intratumoral microbiome on tumor occurrence, progression, prognosis and treatment.
Gao F; Yu B; Rao B; Sun Y; Yu J; Wang D; Cui G; Ren Z
Front Immunol; 2022; 13():1051987. PubMed ID: 36466871
[TBL] [Abstract][Full Text] [Related]
20. LINC00511, a future star for the diagnosis and therapy of digestive system malignant tumors.
Ji D; Feng H; Hou L; Xu Y; Wang X; Zhao W; Pei H; Zhao Q; Chen Q; Tan G
Pathol Res Pract; 2023 Apr; 244():154382. PubMed ID: 36868095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
